Related Experiment Video
Updated: Jul 5, 2026

Retroperitoneal Laparoscopic Debridement and Drainage for Pancreatic Abscess
Published on: March 15, 2024
How should peritoneal-dialysis-associated peritonitis be treated?
1Renal Electrolyte Division, The University of Pittsburgh School of Medicine, 3504 Fifth Avenue, Suite 3504, Pittsburgh, PA 15213, USA. piraino@pitt.edu
Abstract:
In this Practice Point commentary, we discuss Wiggins et al.'s systematic review of the treatment of peritonitis, a serious problem in peritoneal dialysis patients. Wiggins and co-workers reported that most antibiotic classes were similarly effective for the treatment of peritonitis. Despite the limited data available, the investigators found that the intraperitoneal route was more effective than the intravenous route in preventing treatment failure, that intermittent dosing of various antibiotics was as effective as continuous administration of these drugs, and that glycopeptide-based regimens were more likely than first-generation cephalosporins to achieve a complete cure. Here, we discuss the importance of treating peritonitis and the lack of and limitations of existing data, and emphasize the urgent need for well-designed, large randomized trials in this area.
Insights
Peritonitis treatment in peritoneal dialysis patients shows most antibiotics are effective. Intraperitoneal administration and glycopeptide regimens appear more successful than intravenous routes and cephalosporins, highlighting the need for more research.
Area of Science:
- Nephrology
- Infectious Diseases
- Peritoneal Dialysis
Background:
- Peritonitis is a significant complication for patients undergoing peritoneal dialysis.
- Existing data on optimal peritonitis treatment is limited and often lacks robust evidence.
Discussion:
- This commentary reviews a systematic review on peritonitis treatment in peritoneal dialysis.
- It highlights findings regarding antibiotic efficacy, administration routes, dosing, and specific drug classes.
Key Insights:
- Intraperitoneal antibiotic administration demonstrated higher efficacy than intravenous routes.
- Intermittent antibiotic dosing was as effective as continuous administration.
- Glycopeptide-based regimens were associated with higher cure rates compared to first-generation cephalosporins.
Outlook:
- There is an urgent need for large, well-designed randomized controlled trials to establish definitive treatment guidelines.
- Further research is crucial to optimize peritonitis management and improve patient outcomes in peritoneal dialysis.
Related Concept Videos
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
Peritoneal Dialysis I: Introduction and Procedure
Peritoneal Dialysis III: Nursing Management
Acute Pyelonephritis II: Diagnostic Studies and Management
Acute Kidney Injury V: Interprofessional Care
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:

